WARD COPD

WARD 24/7 > Projects > WARD Medical > WARD COPD

WARD-COPD: Wireless Assessment of Respiratory and Circulatory Distress in Chronic Obstructive Pulmonary Disease

Study design

Prospective observational study

Sample size

200 participants


Study sites

Bispebjerg Hospital


Inclusion criteria

Adult (>18 years) patients admitted with acute exacerbation of COPD (admission diagnosis)

 

Study procedures

Included patients are monitored with WARD equipment from admission and up to 4 days forward during hospitalization.


Primary outome

Severe adverse events (SAE’s) at 30 days and 6 months after study inclusion. 


Primary Investigator

Mikkel Elvekjær, MD, PhD student

 

NCT

NCT03660501